MedPath

LEUSTATIN 1MG/ML

LEUSTATIN 1MG/ML

Discontinued
DIN Number

02022117

Drug Class

Human

Market Date

Dec 31, 1993

Company
HC

Janssen Inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02022117
AIG Number0124270001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
L01BB04 CLADRIBINE
Product Specifications
Dosage FormSolution
Route of AdministrationIntravenous
AHFS Classification10:00.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

CLADRIBINEActive
Strength: 1 MG / ML
Monograph: CLADRIBINE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.